Central Bank of India partners with Canara Robeco AMC to distribute mutual fund products
Shares of Central Bank of India Ltd ended at ₹40.08, down by ₹0.35, or 0.87%, on the BSE.
Uncategorized
PFC shares fall after it transfers Saswad Transmission to Maharashtra State Electricity Transmission
Power Finance Corporation sold Saswad Transmission to Maharashtra State Electricity Transmission for ₹3.79 crore; shares fell 2% to ₹412.20.
Indian vaccine maker Bharat Biotech said to consider $500 million IPO: Report
Bharat Biotech International Ltd may launch an IPO to raise over 500 million dollars. The Hyderabad firm has delivered 9 billion vaccine doses and its portfolio includes Covid-19 and hepatitis B.
Paras Defence enters semiconductor space with new subsidiary
Paras Defence and Space Technologies Ltd launched Paras Semiconductors Private Ltd to enter India’s semiconductor sector, focusing on AI, HPC, and 3D packaging OSAT, holding a 70% stake.
Small caps offer selective opportunities after correction; avoid expensive IPOs: Roha Venture CIO
According to Dhiraj Sachdev, CIO of Roha Venture, markets may continue to remain selective rather than broadly directional, with stock-specific opportunities emerging after the correction. Investors, he said, should prioritise sustainable earnings growth and valuation discipline while navigating volatility.
GMDC gets environmental clearance for 3 MTPA Kutch lignite and limestone project
GMDC has received environmental clearance for its Lakhpat–Punrajpur lignite and limestone mine in Kutch, strengthening long-term production visibility and expanding its mineral resource base in Gujarat.
Watch | Emkay’s Seshadri Sen: IT sell-off overdone, stick to largecaps amid AI disruption
Seshadri Sen, Head of Research & Strategist at Emkay Global Financial Services, says the IT sell-off has overshot fundamentals, creating a tactical opportunity in large-cap names. Despite AI disruption, firms will still need IT vendors for integration and deployment, and…
Markets log third-worst weekly fall of 2026; Nifty IT sees sharp February decline
The fall in blue-chip stocks deepened after the Nifty 50 slipped below its 200-day moving average. With the latest downturn, all gains recorded after the Union Budget 2026 have been wiped out.
Zydus Lifesciences moves closer to US launch of key cancer drug biosimilar
Zydus Lifesciences’ in-licensed pembrolizumab biosimilar met the primary endpoint in a pivotal PK study, paving the way for a near-term USFDA filing and entry into the North American market.
Coal India ready for summer demand surge; shares rise 2%
Coal India Limited assures readiness for summer demand with 175.5 MT coal available, record stocks at pitheads and power plants, aiming to reduce imports amid rising international prices.